Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

about

Dabrafenib Therapy in 30 Patients with Melanoma Metastatic to the Brain: a Single-centre Controlled Retrospective Study in Hungary.

P2860

Q48347310-DC45D9C4-4344-4525-9E07-131BE53ED8D4

P2860

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

Item

http://www.wikidata.org/entity/Q36652790

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@ast

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@en

type

Item

label

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@ast

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@en

prefLabel

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@ast

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@en

P1476

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

@en

P2093

A Battaglia

http://www.w3.org/2001/XMLSchema#string

A Intelisano

http://www.w3.org/2001/XMLSchema#string

C Riviello

http://www.w3.org/2001/XMLSchema#string

E Cocorocchio

http://www.w3.org/2001/XMLSchema#string

E Pennacchioli

http://www.w3.org/2001/XMLSchema#string

G Spadola

http://www.w3.org/2001/XMLSchema#string

G Tosti

http://www.w3.org/2001/XMLSchema#string

L Pala

http://www.w3.org/2001/XMLSchema#string

M Barberis

http://www.w3.org/2001/XMLSchema#string

M Di Leo

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Mutations of the BRAF gene in human cancer

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview

Comprehensive molecular characterization of gastric adenocarcinoma

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

P304

624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2016.624

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pier Francesco Ferrucci

Sara Gandini

Chiara Martinoli

Salvatore Alfieri

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26981153

http://www.w3.org/2001/XMLSchema#string

P932

4778691

http://www.w3.org/2001/XMLSchema#string

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

about

P2860

P2860

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932